title: Successful Treatment of Congenital Erythroleukemia With Low-Dose Cytosine Arabinoside.
authors.affiliation: Department of Haematology and Oncology, Princess Margaret Hospital for Children, Perth, Western Australia.
authors.forename: Gail C
authors.initials: GC
authors.lastname: Halliday
authors.affiliation: Department of Haematology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Palmyra DC, Western Australia.|School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Perth, Western Australia.
authors.forename: John
authors.initials: J
authors.lastname: O'Reilly
authors.affiliation: Department of Haematology and Oncology, Princess Margaret Hospital for Children, Perth, Western Australia.
authors.forename: Chloe
authors.initials: C
authors.lastname: Kelsey
authors.affiliation: Department of Haematology and Oncology, Princess Margaret Hospital for Children, Perth, Western Australia.|School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia.|Telethon Kids Institute, University of Western Australia, Perth, Western Australia.
authors.forename: Catherine H
authors.initials: CH
authors.lastname: Cole
authors.affiliation: Department of Haematology and Oncology, Princess Margaret Hospital for Children, Perth, Western Australia.|School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia.|Telethon Kids Institute, University of Western Australia, Perth, Western Australia.
authors.forename: Rishi S
authors.initials: RS
authors.lastname: Kotecha
mesh_terms: D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D007231:Infant, Newborn; D007275:Injections, Intravenous; D004915:Leukemia, Erythroblastic, Acute / Q000097:blood / Q000151:congenital* / Q000188:drug therapy*; D008297:Male
chemical_list: D003561:Cytarabine